Essity: Interim Report Quarter 2, 2025
Organic growth and sequentially higher margin in a weak economy
Quarter 2, 2025
- Net sales decreased 6.6% to
SEK 34,185m (36,617). Excl. currency translation effects, net sales increasedSEK 699m . - Organic sales growth amounted to 1.9%, of which volume accounted for 0.2% and price/mix 1.7%
- EBITA decreased 12% to
SEK 4,628m (5,237) - EBITA excl. IAC decreased 13% to
SEK 4,693m (5,398). Excl. currency translation effects, EBITA excl. IAC decreased 4%, corresponding toSEK 211m . - EBITA margin excl. IAC amounted to 13.7% (14.7)
- ROCE amounted to 16.7% (17.9) and ROCE excl. IAC to 16.9% (18.5)
- Profit for the period, total operations, amounted to
SEK 3,053m (3,333) - Earnings per share, total operations, amounted to
SEK 4.39 (4.72) - A new
SEK 3bn share buyback program was launched onApril 24, 2025 Ulrika Kolsrud assumed her role as new President and CEO onJune 1, 2025
CEO'S COMMENTS
For the second quarter, we achieved a positive organic sales growth and earnings of
Organic growth in a weak economy
In Consumer Goods, Incontinence Products Retail and Feminine Care reported strong growth, while the Baby Care market remained challenging with low birth rates and intense competition. Reduced activity in the hotel and restaurant sector resulted in lower demand in Professional Hygiene and, in the healthcare sector, weaker conditions in certain markets negatively affected sales for Incontinence Products Health Care. Despite these challenges, we delivered yet another quarter of positive organic sales growth.
Continued sequential improvement in margins
The company's gross margin improved, both compared to the second quarter of 2024 and sequentially, as higher sales prices offset increased costs of goods sold, including trade tariffs. However, the limited volume growth resulted in lower cost coverage, thereby negatively impacting earnings. In addition, both net sales and earnings were negatively impacted by currency translation effects. Overall, we delivered stable earnings of
Investments for the future
Our solutions are necessary regardless of the economic situation and we are working continuously to strengthen our offering across the low-cost - value - premium spectrum to meet the different needs and financial situations of customers and consumers. One example is the upgrades carried out in Consumer Tissue, Cushelle Simply Soft and Lotus Comfort, which were launched last quarter to reinforce the value segment and attract price-sensitive consumers. Aligned with our strategy, we are implementing several initiatives to grow in our most profitable categories in attractive markets. We are seeing good effects of several growth initiatives, for example in JOBST Lymphology, Cutimed Advanced Wound Care, TENA Men, Tork PeakServe and
"I see significant potential in the company and it is with great enthusiasm that I take on the task of accelerating Essity's profitable growth together with all fantastic employees."
Increased focus on customers and consumers
This is my first interim report as President and CEO. I see significant potential in the company, and it is with great enthusiasm that I take on the task of accelerating Essity's profitable growth together with all fantastic employees. Since assuming my role, I have focused on broadening my view of the company by seeking external perspectives and spending time out in the organization. It is inspiring to meet so many committed and knowledgeable colleagues and I never cease to be impressed by the strong culture here at Essity. By further strengthening our customer and consumer focus, we will continue to develop and increase our competitiveness in order to grow and gain market share.
We currently touch the lives of 1 billion people every day in 150 countries, meaning that 7 billion people have yet to discover our products. We strive to reach more people with our leading hygiene and health solutions, improving the quality of life of those we reach while creating long-term shareholder value.
Invitation to presentation
President and CEO
Link to the live presentation, which can also be viewed afterwards:
https://essity.videosync.fi/2025-07-17
Contact information for conference call with the possibility to ask questions:
SWE: +46 (0) 8 505 204 24
Please call in well in advance of the start of the presentation. Indicate: "Essity".
For additional information, please contact:
Sandra Åberg, Vice President Investor Relations, tel: +46 (0) 70 564 96 89
Per Lorentz, Vice President Corporate Communications, tel: +46 (0) 73 313 30 55
NB: This information is such that Essity Aktiebolag (publ) is obligated to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. This report has been prepared in both Swedish and English versions. In case of variations in the content between the two versions, the Swedish version shall govern. The information was submitted for publication, through the agency of
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/essity/r/interim-report-quarter-2--2025,c4208087
The following files are available for download:
Essity Report ENG |
View original content:https://www.prnewswire.com/news-releases/essity-interim-report-quarter-2-2025-302507657.html
SOURCE Essity
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Dollar Tree upgraded on earnings upside potential despite ongoing traffic woes
- Darryl Drake Jr. Named President of Valor as Vector Science and Therapeutics Targets the Performance Medicine Market
- Legendary Entertainment and Warner Bros. Pictures Unveil Dune: Part Three Trailer and Behind-the-Scenes Images Showcasing Abu Dhabi as Arrakis
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
Stock Buyback, EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share